Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 109

    1.

    Differential roles of cardiomyocyte and macrophage peroxisome proliferator-activated receptor gamma in cardiac fibrosis.

    Caglayan E, Stauber B, Collins AR, Lyon CJ, Yin F, Liu J, Rosenkranz S, Erdmann E, Peterson LE, Ross RS, Tangirala RK, Hsueh WA.

    Diabetes. 2008 Sep;57(9):2470-9. Epub 2008 May 28.PMID: 18511847 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Peroxisome proliferator-activated receptor gamma plays a critical role in inhibition of cardiac hypertrophy in vitro and in vivo.

    Asakawa M, Takano H, Nagai T, Uozumi H, Hasegawa H, Kubota N, Saito T, Masuda Y, Kadowaki T, Komuro I.

    Circulation. 2002 Mar 12;105(10):1240-6.PMID: 11889020 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Effect of pioglitazone on the expression of inflammatory cytokines in attenuating rat cardiomyocyte hypertrophy.

    Ye P, Yang W, Wu SM, Sheng L.

    Methods Find Exp Clin Pharmacol. 2006 Dec;28(10):691-6.PMID: 17235413 [PubMed - indexed for MEDLINE]Related articles

    4.

    Peroxisome proliferated-activated receptor gamma ligand, Pioglitazone, does not prevent hepatic fibrosis in mice.

    Da Silva Morais A, Abarca-Quinones J, Horsmans Y, Stärkel P, Leclercq IA.

    Int J Mol Med. 2007 Jan;19(1):105-12.PMID: 17143554 [PubMed - indexed for MEDLINE]Related articles

    5.

    Cardiomyocyte-specific knockout and agonist of peroxisome proliferator-activated receptor-gamma both induce cardiac hypertrophy in mice.

    Duan SZ, Ivashchenko CY, Russell MW, Milstone DS, Mortensen RM.

    Circ Res. 2005 Aug 19;97(4):372-9. Epub 2005 Jul 28.PMID: 16051889 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Osteopontin modulates angiotensin II-induced fibrosis in the intact murine heart.

    Collins AR, Schnee J, Wang W, Kim S, Fishbein MC, Bruemmer D, Law RE, Nicholas S, Ross RS, Hsueh WA.

    J Am Coll Cardiol. 2004 May 5;43(9):1698-705.PMID: 15120833 [PubMed - indexed for MEDLINE]Related articles

    7.

    Pioglitazone increases macrophage apoptosis and plaque necrosis in advanced atherosclerotic lesions of nondiabetic low-density lipoprotein receptor-null mice.

    Thorp E, Kuriakose G, Shah YM, Gonzalez FJ, Tabas I.

    Circulation. 2007 Nov 6;116(19):2182-90. Epub 2007 Oct 22.PMID: 17967777 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    The peroxisome proliferator-activated receptor-gamma agonist pioglitazone represses inflammation in a peroxisome proliferator-activated receptor-alpha-dependent manner in vitro and in vivo in mice.

    Orasanu G, Ziouzenkova O, Devchand PR, Nehra V, Hamdy O, Horton ES, Plutzky J.

    J Am Coll Cardiol. 2008 Sep 2;52(10):869-81. Epub 2008 Jul 2.PMID: 18755353 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance.

    Odegaard JI, Ricardo-Gonzalez RR, Goforth MH, Morel CR, Subramanian V, Mukundan L, Red Eagle A, Vats D, Brombacher F, Ferrante AW, Chawla A.

    Nature. 2007 Jun 28;447(7148):1116-20. Epub 2007 May 21.PMID: 17515919 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Peroxisome proliferator-activated receptor-gamma regulates the expression of alveolar macrophage macrophage colony-stimulating factor.

    Bonfield TL, Thomassen MJ, Farver CF, Abraham S, Koloze MT, Zhang X, Mosser DM, Culver DA.

    J Immunol. 2008 Jul 1;181(1):235-42.PMID: 18566389 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Defective peroxisomal proliferators activated receptor gamma activity due to dominant-negative mutation synergizes with hypertension to accelerate cardiac fibrosis in mice.

    Kis A, Murdoch C, Zhang M, Siva A, Rodriguez-Cuenca S, Carobbio S, Lukasik A, Blount M, O'Rahilly S, Gray SL, Shah AM, Vidal-Puig A.

    Eur J Heart Fail. 2009 Jun;11(6):533-41. Epub 2009 Apr 24.PMID: 19395708 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Effect of pioglitazone, a peroxisome proliferator-activated receptor gamma agonist, on ischemia-reperfusion injury in rats.

    Cao Z, Ye P, Long C, Chen K, Li X, Wang H.

    Pharmacology. 2007;79(3):184-92. Epub 2007 Mar 14.PMID: 17356310 [PubMed - indexed for MEDLINE]Related articles

    13.

    Role of osteopontin in cardiac fibrosis and remodeling in angiotensin II-induced cardiac hypertrophy.

    Matsui Y, Jia N, Okamoto H, Kon S, Onozuka H, Akino M, Liu L, Morimoto J, Rittling SR, Denhardt D, Kitabatake A, Uede T.

    Hypertension. 2004 Jun;43(6):1195-201. Epub 2004 May 3.PMID: 15123578 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Angiotensin II type-1 receptor activation in the adult heart causes blood pressure-independent hypertrophy and cardiac dysfunction.

    Ainscough JF, Drinkhill MJ, Sedo A, Turner NA, Brooke DA, Balmforth AJ, Ball SG.

    Cardiovasc Res. 2009 Feb 15;81(3):592-600. Epub 2008 Aug 14.PMID: 18703536 [PubMed - indexed for MEDLINE]Related articles

    16.

    Peroxisome proliferator-activated receptor-gamma agonists attenuate angiotensin II-induced collagen type I expression in adventitial fibroblasts.

    Zhang J, Fang NY, Gao PJ, Wu LY, Han WQ, Guo SJ, Shen WL, Zhu DL.

    Clin Exp Pharmacol Physiol. 2008 Jan;35(1):72-7.PMID: 18047631 [PubMed - indexed for MEDLINE]Related articles

    17.

    Adiponectin protects against angiotensin II-induced cardiac fibrosis through activation of PPAR-alpha.

    Fujita K, Maeda N, Sonoda M, Ohashi K, Hibuse T, Nishizawa H, Nishida M, Hiuge A, Kurata A, Kihara S, Shimomura I, Funahashi T.

    Arterioscler Thromb Vasc Biol. 2008 May;28(5):863-70. Epub 2008 Feb 28.PMID: 18309113 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Estrogen inhibits cardiac hypertrophy: role of estrogen receptor-beta to inhibit calcineurin.

    Pedram A, Razandi M, Lubahn D, Liu J, Vannan M, Levin ER.

    Endocrinology. 2008 Jul;149(7):3361-9. Epub 2008 Mar 27.PMID: 18372323 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Pioglitazone attenuates cardiac hypertrophy in rats with salt-sensitive hypertension: role of activation of AMP-activated protein kinase and inhibition of Akt.

    Kato MF, Shibata R, Obata K, Miyachi M, Yazawa H, Tsuboi K, Yamada T, Nishizawa T, Noda A, Cheng XW, Murate T, Koike Y, Murohara T, Yokota M, Nagata K.

    J Hypertens. 2008 Aug;26(8):1669-76.PMID: 18622247 [PubMed - indexed for MEDLINE]Related articles

    20.

    Effects of pioglitazone on nitric oxide bioavailability measured using a catheter-type nitric oxide sensor in angiotensin II-infusion rabbit.

    Imanishi T, Kuroi A, Ikejima H, Kobayashi K, Mochizuki S, Goto M, Yoshida K, Akasaka T.

    Hypertens Res. 2008 Jan;31(1):117-25.PMID: 18360026 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data